Standout Papers

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials 2022 2026 2023 2024119
  1. Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials (2022)
    Haohao Zhu, Hui Gao et al. Journal of Hematology & Oncology

Immediate Impact

47 standout
Sub-graph 1 of 17

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Patient‐derived xenograft model in cancer: establishment and applications
2025 Standout
2 intermediate papers

Works of Lin Tian being referenced

Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence
2023
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
2022 Standout

Author Peers

Author Last Decade Papers Cites
Lin Tian 247 88 44 46 45 531
Sophia Lavrentiadou 253 90 43 33 34 535
Lu Zhang 200 53 27 48 47 503
Kalpana K. Bhanumathy 207 67 46 30 32 543
Etimad Huwait 177 60 42 33 55 565
Ruirong Tan 202 59 27 41 40 512
Chunli Yin 275 72 75 45 27 522
Hassan I. El‐Sayyad 185 71 44 49 42 637
Abdulrahman Theyab 176 53 61 43 33 537
Richard Tagne Simo 206 117 68 38 34 599
I. M. Hussaini 202 53 65 33 39 524

All Works

Loading papers...

Rankless by CCL
2026